leptomeningeal metastases
Showing 1 - 25 of 2,615
NSCLC Associated With Leptomeningeal Metastases Trial (Tislelizumab, pemetrexed)
Not yet recruiting
- NSCLC Associated With Leptomeningeal Metastases
- Tislelizumab, pemetrexed
- (no location specified)
Nov 21, 2023
Breast Cancer Female, Leptomeningeal Metastases Trial in Charlottesville (HER2 BATs)
Terminated
- Breast Cancer Female
- Leptomeningeal Metastases
- HER2 BATs
-
Charlottesville, VirginiaUniversity of Virginia
Dec 15, 2022
Non Small Cell Lung Cancer Trial in Hangzhou (Furmonertinib Mesilate Tablets)
Enrolling by invitation
- Non Small Cell Lung Cancer
- Furmonertinib Mesilate Tablets
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, College of Medicine, Zhejiang Uni
Apr 3, 2023
Patients With Leptomeningeal Metastases ((LM) Using CNSide
Recruiting
- Leptomeningeal Metastasis
- +4 more
- CNSide
-
Los Angeles, CaliforniaValkyrie Clinical Trials
Sep 7, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Malignant Tumor in the Leptomeninges Trial in
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +2 more
- Digital Photography
- +3 more
-
Jacksonville, FloridaMayo Clinic in Florida
Feb 28, 2023
Breast Cancer Metastatic, Leptomeningeal Metastasis Trial (Tucatinib Oral Tablet, Capecitabine tablets, Trastuzumab Injection)
Not yet recruiting
- Breast Cancer Metastatic
- Leptomeningeal Metastasis
- Tucatinib Oral Tablet
- +2 more
- (no location specified)
Mar 23, 2023
Leptomeningeal Metastases, Leptomeningeal Disease Trial in Tampa (Avelumab, Whole Brain Radiotherapy)
Active, not recruiting
- Leptomeningeal Metastases
- Leptomeningeal Disease
- Avelumab
- Whole Brain Radiotherapy
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Aug 19, 2022
NSCLC, EGFR Activating Mutation, Brain Metastases Trial in Beijing (TY-9591 Tablets)
Recruiting
- NSCLC
- +3 more
- TY-9591 Tablets
-
Beijing, Beijing, ChinaNational Cancer Center/Cancer Hospitial,Chinese Academy of Medic
May 14, 2022
Brain Metastases, Leptomeningeal Metastasis Trial in United States (GDC-0084, whole brain radiation therapy radiation)
Recruiting
- Brain Metastases
- Leptomeningeal Metastasis
- GDC-0084
- whole brain radiation therapy radiation
-
Miami, Florida
- +9 more
Jan 3, 2023
Leptomeningeal Metastases Trial in Changchun (Pemetrexed (1), Pemetrexed (2), Folic Acid)
Recruiting
- Leptomeningeal Metastases
- Pemetrexed (1)
- +4 more
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Sep 29, 2022
Malignant Tumor, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the Leptomeninges Trial in Duarte
Recruiting
- Malignant Neoplasm
- +4 more
- Chimeric Antigen Receptor T-Cell Therapy
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 14, 2022
NSCLC, Leptomeningeal Metastases, Brain Metastases Trial in United States (Tesevatinib)
Completed
- Non-Small Cell Lung Cancer
- +2 more
-
Beverly Hills, California
- +6 more
Mar 7, 2022
Leptomeningeal Metastases Trial in United States (Deferoxamine (DFO))
Recruiting
- Leptomeningeal Metastases
- Deferoxamine (DFO)
-
Basking Ridge, New Jersey
- +6 more
Jun 27, 2022
Leptomeningeal Metastases Trial in United States (Involved-field Photon Radiation Therapy, Proton Craniospinal Irradiation
Active, not recruiting
- Leptomeningeal Metastases
- Involved-field Photon Radiation Therapy
- +3 more
-
Basking Ridge, New Jersey
- +7 more
Jul 22, 2022
Neuroblastoma, CNS Metastases, Leptomeningeal Metastases Trial in Worldwide (131I-omburtamab)
Recruiting
- Neuroblastoma
- +2 more
- 131I-omburtamab
-
Los Angeles, California
- +11 more
Dec 17, 2021
Metastatic Breast Cancer, Advanced Non-Small Cell Squamous Lung Cancer, Solid Tumor, Adult Trial (Patritumab deruxtecan)
Not yet recruiting
- Metastatic Breast Cancer
- +2 more
- Patritumab deruxtecan
- (no location specified)
May 9, 2023
Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Chicago (Pemetrexed)
Completed
- Brain and Central Nervous System Tumors
- +10 more
-
Chicago, IllinoisRobert H. Lurie Comprehensive Cancer Center at Northwestern Univ
Sep 3, 2021
Non Small Cell Lung Cancer Metastatic, Leptomeningeal Metastasis, Brain Metastases Trial in France (Osimertinib)
Recruiting
- Non Small Cell Lung Cancer Metastatic
- +3 more
-
Aix-en-Provence, France
- +36 more
Jun 28, 2022
Leptomeningeal Metastasis, Lung Cancer Trial in Hebei (Nimotuzumab)
Recruiting
- Leptomeningeal Metastasis
- Lung Cancer
-
Hebei, Shijiazhuang/hebei, China
- +1 more
Apr 18, 2021
Brain Metastases, Adult Trial in Rozzano (Silibinin)
Recruiting
- Brain Metastases, Adult
- Silibinin
-
Rozzano, Milano, ItalyIRCCS Humanitas Research Hospital
Mar 20, 2023
Meningeal Carcinomatosis Trial in Amsterdam (lumbar puncture)
Completed
- Meningeal Carcinomatosis
- lumbar puncture
-
Amsterdam, Netherlands
- +1 more
Jan 19, 2021
Breast Cancer Trial in Montpellier (blood samples)
Completed
- Breast Cancer
- blood samples
-
Montpellier, FranceInstitut régional du Cancer de Montpellier
Oct 16, 2020
Metastatic Breast Cancer, Leptomeningeal Disease Trial in United States (Tucatinib, Trastuzumab, Capecitabine)
Active, not recruiting
- Metastatic Breast Cancer
- Leptomeningeal Disease
- Tucatinib
- +2 more
-
Birmingham, Alabama
- +8 more
Oct 12, 2021